Ukraine vs United Arab Emirates: Prevalence rate of hypertension in men aged 30-79
Ukraine
44.5
in 2019
United Arab Emirates
43.9
in 2019
Ukraine rank
42nd
United Arab Emirates rank
44th
Prevalence rate of hypertension in men aged 30-79 over time
- Ukraine
- United Arab Emirates
How they compare
Ukraine currently reports 44.5 against 43.9 in United Arab Emirates, a difference of 0.6.
Across all 30 years both countries report, Ukraine has been ahead every year.
Ukraine ranks 42nd and United Arab Emirates ranks 44th of 195 countries.
Ukraine has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ukraine | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 51.63 | 37.46 | 14.17 | Ukraine |
| 2000s | 51.5 | 38.87 | 12.63 | Ukraine |
| 2010s | 47.38 | 41.83 | 5.55 | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Ukraine or United Arab Emirates?
- Ukraine, at 44.5 against 43.9 in United Arab Emirates as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Ukraine and United Arab Emirates?
- 0.6, with Ukraine ahead.
- How many years of comparable data are there for Ukraine and United Arab Emirates?
- 30 years are reported by both, from 1990 to 2019.
- How do Ukraine and United Arab Emirates rank globally for prevalence rate of hypertension in men aged 30-79?
- Ukraine ranks 42nd and United Arab Emirates ranks 44th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.